During a live event, Andrew Brunner, MD, and participants discussed escalating therapy in luspatercept-refractory LR-MDS. For patients with lower-risk myelodysplastic syndromes (LR-MDS) and ...
Retrofitting legacy bioprocessing equipment with modern PAT tools requires targeted sensor, software, and change-control ...
Search by keyword Use any search term (eg. road, tree, water, fence) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results